bluebird bio Inc. (BLUE) News Headlines

▮ More

Date

Headline

9/8/2021 9:00:56 AM Bluebird Bio Secures $75 Mln In Private Placement Equity Financing

9/8/2021 7:37:09 AM Bluebird Bio Says Secures $75 Mln In Private Placement Equity Financing

8/9/2021 7:13:54 AM Bluebird Bio Q2 Net Loss $241.7 Mln Vs. Net Loss $21.5 Mln Last Year

6/7/2021 9:54:49 AM BLUE Shares Up After FDA Lifts Clinical Hold For Sickle Cell Disease, ?-Thalassemia Studies

6/7/2021 9:03:54 AM Bluebird Bio: FDA Lifts Clinical Hold On Sickle Cell Disease And ?-Thalassemia Studies - Quick Facts

3/29/2021 8:01:21 AM FDA Approves First Cell-Based Gene Therapy For Adult Multiple Myeloma Patients

3/10/2021 7:23:39 AM Bluebird Bio Provides Updated Findings From Reported Case Of Acute Myeloid Leukemia In LentiGlobin

2/24/2021 1:37:36 AM BLUE To Face FDA Next Month, SNSS Catches Eyes, ADVM On Watch

2/17/2021 1:21:51 AM BLUE Hit By SCD Trial Blues, CRTX Plunges On Partial Hold, SESN To Face FDA In August

1/11/2021 6:44:30 AM Bluebird Bio's Board Approves Plan To Separate Into Two Companies - Quick Facts

1/11/2021 6:37:59 AM Bluebird Bio To Retain Focus On Severe Genetic Disease And To Launch Its Oncology Business As New Entity

12/4/2020 8:06:24 AM Magenta Therapeutics And Bluebird Bio Announce A Phase 2 Trial Collaboration To Evaluate Magenta's MGTA-145

11/4/2020 10:33:14 PM Bluebird Bio Q3 Loss Narrows; Adjusts LentiGlobin BLA Submission Timing To Late 2022

11/4/2020 5:31:19 PM Bluebird Bio Q3 Loss/Shr $2.94; Adjusts LentiGlobin BLA Submission Timing To Late 2022

10/2/2020 5:45:31 AM Bluebird Bio: European Medicines Agency To Review Eli-cel MAA Under Accelerated Assessment

10/2/2020 5:32:27 AM Bluebird Bio: EMA Accepts MAA For Investigational Elivaldogene Autotemcel Gene Therapy

8/11/2020 7:04:51 AM Bluebird Bio Appoints Denice Torres To Board

7/30/2020 3:08:15 AM ALEC Falls Despite Promising Results, DNLI Makes Progress In COVID-19 Trial, EARS, ONTX On Watch

5/18/2020 9:35:45 PM Bluebird Bio Prices Underwritten Public Offering Of 9.09 Mln Shares At $55.00/shr

5/18/2020 7:03:37 AM Bluebird Bio Commences Public Offering Of $400 Mln Shares

Bluebird Bio Inc. (BLUE)